Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000530226 | SCV000627981 | pathogenic | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2017-10-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal at codon 2371 (p.Trp2371*) of the FBN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FBN1 are known to be pathogenic. This particular variant has been reported in the literature in an individual with Marfan syndrome (PMID: 21542060). For these reasons, this variant has been classified as Pathogenic. |
Centre of Medical Genetics, |
RCV000663930 | SCV002025432 | pathogenic | Marfan syndrome | 2021-03-01 | criteria provided, single submitter | research | PM2, PVS1, PP4 |
Center for Medical Genetics Ghent, |
RCV000663930 | SCV000787301 | likely pathogenic | Marfan syndrome | 2017-11-07 | no assertion criteria provided | clinical testing |